Jack Phu1,2, Sieu K Khuu2, Bang V Bui3, Michael Kalloniatis1,2. 1. Centre for Eye Health, University of New South Wales Sydney, Sydney, NSW, Australia. 2. School of Optometry and Vision Science, University of New South Wales Sydney, Sydney, NSW, Australia. 3. Department of Optometry and Vision Sciences, University of Melbourne, Parkville, VIC, Australia.
Abstract
PURPOSE: To predict the lead time (difference in time taken for a visual field [VF] defect to be detected) obtained when using stimulus sizes within or near the size of the critical area of spatial summation (Ac), and to test these predictions using sensitivity measurements from a cohort of glaucoma patients. METHODS: Thirty-seven patients with early open-angle glaucoma and 60 healthy observers underwent VF testing on the Humphrey Field Analyzer in full threshold mode using Goldmann stimulus sizes I to V (GI-V) across the 30-2 test grid. We used the sensitivities measured using GI to V in healthy patients to predict the lead time gained by using stimulus sizes within the size of Ac at all locations within the 30-2 grid. Then, we used sensitivities measured in the glaucoma patients to test this predictive model. RESULTS: Median lead time to VF defect detection when using stimulus sizes within Ac compared with stimulus sizes larger than Ac was 4.1 years across the 30-2 test grid (interquartile range, 3.1 and 5.1 years). Sensitivities of the glaucoma patients showed good agreement with the predictive model of lead time gained (77.5%-84.3% were within ±3 dB). CONCLUSIONS: Our model predicted substantial lead time differences when using stimulus sizes within or near Ac. Such stimulus sizes could potentially detect VF defects, on average, 4 years earlier than current paradigms. TRANSLATIONAL RELEVANCE: Stimulus sizes within or near Ac may be more suitable for early detection of glaucomatous VF defects. Larger stimulus sizes may be more suitable for later monitoring of established disease.
PURPOSE: To predict the lead time (difference in time taken for a visual field [VF] defect to be detected) obtained when using stimulus sizes within or near the size of the critical area of spatial summation (Ac), and to test these predictions using sensitivity measurements from a cohort of glaucoma patients. METHODS: Thirty-seven patients with early open-angle glaucoma and 60 healthy observers underwent VF testing on the Humphrey Field Analyzer in full threshold mode using Goldmann stimulus sizes I to V (GI-V) across the 30-2 test grid. We used the sensitivities measured using GI to V in healthy patients to predict the lead time gained by using stimulus sizes within the size of Ac at all locations within the 30-2 grid. Then, we used sensitivities measured in the glaucoma patients to test this predictive model. RESULTS: Median lead time to VF defect detection when using stimulus sizes within Ac compared with stimulus sizes larger than Ac was 4.1 years across the 30-2 test grid (interquartile range, 3.1 and 5.1 years). Sensitivities of the glaucoma patients showed good agreement with the predictive model of lead time gained (77.5%-84.3% were within ±3 dB). CONCLUSIONS: Our model predicted substantial lead time differences when using stimulus sizes within or near Ac. Such stimulus sizes could potentially detect VF defects, on average, 4 years earlier than current paradigms. TRANSLATIONAL RELEVANCE: Stimulus sizes within or near Ac may be more suitable for early detection of glaucomatous VF defects. Larger stimulus sizes may be more suitable for later monitoring of established disease.
Authors: Tony Redmond; David F Garway-Heath; Margarita B Zlatkova; Roger S Anderson Journal: Invest Ophthalmol Vis Sci Date: 2010-07-29 Impact factor: 4.799
Authors: B C Chauhan; D F Garway-Heath; F J Goñi; L Rossetti; B Bengtsson; A C Viswanathan; A Heijl Journal: Br J Ophthalmol Date: 2008-01-22 Impact factor: 4.638
Authors: Pádraig J Mulholland; Tony Redmond; David F Garway-Heath; Margarita B Zlatkova; Roger S Anderson Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Jack Phu; Sieu K Khuu; Lisa Nivison-Smith; Barbara Zangerl; Agnes Yiu Jeung Choi; Bryan W Jones; Rebecca L Pfeiffer; Robert E Marc; Michael Kalloniatis Journal: Invest Ophthalmol Vis Sci Date: 2017-09-01 Impact factor: 4.799
Authors: Janelle Tong; Jack Phu; Sieu K Khuu; Nayuta Yoshioka; Agnes Y Choi; Lisa Nivison-Smith; Robert E Marc; Bryan W Jones; Rebecca L Pfeiffer; Michael Kalloniatis; Barbara Zangerl Journal: Am J Ophthalmol Date: 2019-05-10 Impact factor: 5.258
Authors: Jack Phu; Henrietta Wang; Sephora Miao; Lydia Zhou; Sieu K Khuu; Michael Kalloniatis Journal: Optom Vis Sci Date: 2018-10 Impact factor: 1.973